Market Value4,081,490,710
Total Holdings53
File Date2023-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
ALLO / Allogene Therapeutics, Inc.
ALLK / Allakos Inc.
SWTX / SpringWorks Therapeutics, Inc.
HOOK / HOOKIPA Pharma Inc.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
PSTX / Poseida Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
BDTX / Black Diamond Therapeutics, Inc.
PRTA / Prothena Corporation plc
MORF / Morphic Holding, Inc.
KYMR / Kymera Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
RVMD / Revolution Medicines, Inc.
SURF / Surface Oncology Inc
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
EUCR / Eucrates Biomedical Acquisition Corp
KDNY / Chinook Therapeutics Inc
ACET / Adicet Bio, Inc.
SRPT / Sarepta Therapeutics, Inc.
JANX / Janux Therapeutics, Inc.
JNJ / Johnson & Johnson Call
VYGR / Voyager Therapeutics, Inc.
ANAB / AnaptysBio, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
ALGS / Aligos Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
OVID / Ovid Therapeutics Inc.
BPMC / Blueprint Medicines Corporation
AGLE / Aeglea BioTherapeutics Inc
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
THRD / Third Harmonic Bio, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
CGEM / Cullinan Therapeutics, Inc.
SELB / Selecta Biosciences Inc
BEAM / Beam Therapeutics Inc.
ARVN / Arvinas, Inc.
TCRX / TScan Therapeutics, Inc.
PRME / Prime Medicine, Inc.
ERAS / Erasca, Inc.
CYT / Cyteir Therapeutics, Inc.
ALEC / Alector, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
DYN / Dyne Therapeutics, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
CMAXW / CareMax Inc - Warrants (08/06/2026)
MGNX / MacroGenics, Inc.
NUVB / Nuvation Bio Inc.
ITOS / iTeos Therapeutics, Inc.
XNCR / Xencor, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
PRLD / Prelude Therapeutics Incorporated
GRPH / Graphite Bio, Inc.
KRON / Kronos Bio, Inc.
NGM / NGM Biopharmaceuticals, Inc.
GBIO / Generation Bio Co.
JAZZ / Jazz Pharmaceuticals plc
APLS / Apellis Pharmaceuticals, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
ZYME / Zymeworks Inc.
AVIR / Atea Pharmaceuticals, Inc.
EWTX / Edgewise Therapeutics, Inc.
TPST / Tempest Therapeutics, Inc.
PRQR / ProQR Therapeutics N.V.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
KURA / Kura Oncology, Inc.
KURA / Kura Oncology, Inc. Call